BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8261434)

  • 1. A population-based seroepidemiological study of cervical cancer.
    Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
    Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum antibodies against defined epitopes of human papillomavirus L1, E2, and E7 antigens and of HPV DNA with incident cervical cancer.
    Dillner L; Zellbi A; Avall-Lundqvist E; Heino P; Eklund C; Pettersson CA; Forslund O; Hansson BG; Grandien M; Bistoletti P
    Cancer Detect Prev; 1995; 19(5):381-93. PubMed ID: 7585724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls.
    Mann VM; de Lao SL; Brenes M; Brinton LA; Rawls JA; Green M; Reeves WC; Rawls WE
    Cancer Res; 1990 Dec; 50(24):7815-9. PubMed ID: 2174733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
    Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of human papillomavirus antibodies with cervical cancer risk.
    Mandelson MT; Jenison SA; Sherman KJ; Valentine JM; McKnight B; Daling JR; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 1992; 1(4):281-6. PubMed ID: 1338895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus antibody responses among patients with incident cervical carcinoma.
    Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
    J Med Virol; 1997 Aug; 52(4):436-40. PubMed ID: 9260694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients.
    Bavinck JN; Gissmann L; Claas FH; Van der Woude FJ; Persijn GG; Ter Schegget J; Vermeer BJ; Jochmus I; Müller M; Steger G
    J Immunol; 1993 Aug; 151(3):1579-86. PubMed ID: 8393047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Rosenquist K
    Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
    Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
    Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer.
    Nonnenmacher B; Pintos J; Bozzetti MC; Mielzinska-Lohnas I; Lorincz AT; Ikuta N; Schwartsmann G; Villa LL; Schiller JT; Franco E
    Int J STD AIDS; 2003 Apr; 14(4):258-65. PubMed ID: 12716496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomaviruses and other influences on survival from cervical cancer in Panama.
    DeBritton RC; Hildesheim A; De Lao SL; Brinton LA; Sathya P; Reeves WC
    Obstet Gynecol; 1993 Jan; 81(1):19-24. PubMed ID: 8380103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
    Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
    Gynecol Oncol; 2002 May; 85(2):333-8. PubMed ID: 11972397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
    J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
    Walboomers JM; Jacobs MV; Manos MM; Bosch FX; Kummer JA; Shah KV; Snijders PJ; Peto J; Meijer CJ; Muñoz N
    J Pathol; 1999 Sep; 189(1):12-9. PubMed ID: 10451482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
    Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
    Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines.
    Smith JS; Muñoz N; Herrero R; Eluf-Neto J; Ngelangel C; Franceschi S; Bosch FX; Walboomers JM; Peeling RW
    J Infect Dis; 2002 Feb; 185(3):324-31. PubMed ID: 11807714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway.
    Bjørge T; Hakulinen T; Engeland A; Jellum E; Koskela P; Lehtinen M; Luostarinen T; Paavonen J; Sapp M; Schiller J; Thoresen S; Wang Z; Youngman L; Dillner J
    Cancer Res; 1997 Sep; 57(18):3989-92. PubMed ID: 9307283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.